Skip to content

Homoeopathic treatment of psoriasis (a chronic skin disease)

Clinical audit using Psoriasis Disability Index (PDI) and Psoriasis Area and Severity Index (PASI) for utility of homoeopathic medicine in psoriasis patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/05/008559
Enrollment
100
Registered
2017-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Psoriasis

Interventions

Sponsors

National Institute of Homoeopathy Ministry of AYUSH Govt of India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from psoriasis over 3 months 2. Age 18-60 years 3. Both sexes 4. Patients willing to take part in the study and giving written consent

Exclusion criteria

Exclusion criteria: 1. Patients who are too sick for consultation 2. Unable to read patient information sheets and not giving consent to take part 3. Psoriasis with complications like erythroderma and pustules 4. Diagnosed cases of unstable psychiatric illness or other systemic disease affecting quality of life 5. Currently receiving homeopathic treatment for chronic condition(s) 6. Pregnant and lactating women 7. Self-reported immune-compromised state 8. Substance abuse and/or dependence

Design outcomes

Primary

MeasureTime frame
Psoriasis Area Scoring Index (PASI)Timepoint: Baseline and 6 months

Secondary

MeasureTime frame
Dermatological Quality of Life Index (DQLI)Timepoint: Baseline and 6 months;Psoriasis Disability Index (PDI)Timepoint: Baseline and 6 months

Countries

India

Contacts

Public ContactAbhijit Chatterjee

National Institute of Homoeopathy, Ministry of AYUSH, Govt. of India

drac.nih@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026